Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;200(3):305-313.
doi: 10.1007/s00408-022-00538-x. Epub 2022 May 3.

ADAMTS7 Attenuates House Dust Mite-Induced Airway Inflammation and Th2 Immune Responses

Affiliations

ADAMTS7 Attenuates House Dust Mite-Induced Airway Inflammation and Th2 Immune Responses

Anil Kumar Jaiswal et al. Lung. 2022 Jun.

Abstract

Purpose: ADAMTS7 is a secreted metalloproteinase enzyme and proteoglycan associated with the early progression of coronary artery disease. However, there is limited information regarding the role of ADAMTS7 in lung adaptive immunity and inflammation. Thus, we sought to assess whether ADAMTS7 expression in the lung modulates house dust mite (HDM)-induced airway inflammation and Th2 immune response.

Methods: The role of ADAMTS7 in HDM-induced airway disease was assessed in ADAMTS7-deficient (ADAMTS7-/-) mice and compared with the wild-type control mice by flow cytometry, ELISA, and histopathology. Furthermore, the antigen priming capability of dendritic cells (DC) was determined ex vivo by employing coculture with CD4+ OT-II cells.

Results: ADAMTS7-/- mice develop an augmented eosinophilic airway inflammation, mucous cell metaplasia, and increased Th2 immune response to inhaled HDM. In addition, allergen uptake by lung DC and migration to draining mediastinal lymph node were significantly increased in ADAMTS7-/- mice, which shows an enhanced capacity to mount allergen-specific T-cell proliferation and effector Th2 cytokine productions. We propose that the mechanism by which ADAMTS7 negatively regulates DC function involves attenuated antigen uptake and presentation capabilities, which reduces allergic sensitization and Th2 immune responses in the lung.

Conclusion: In aggregate, we provide compelling evidence that ADAMTS7 plays a pivotal role in allergic airway disease and Th2 immunity and would be an attractive target for asthma.

Keywords: ADAMTS7; Allergic airway inflammation (AAI); Lung dendritic cells; Type 2 immune response.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1
Fig. 1
ADAMTS7-deficient mice develop augmented HDM-induced airway inflammation. a Representative PCR analysis of genomic DNA isolated from WT and ADAMTS7−/− lungs and DC. The absence of PCR product indicates ADAMTS7 deletion in ADAMTS7−/− mice. b Diagram shows the HDM administration (i.p., intraperitoneal; i.n. intranasal) and analysis schedule. c Dot plots of BAL and lung cells (from a representative individual of indicated groups of mice and d quantitation of flow cytometry analysis showing the number of total cells (CD45 +), eosinophils (CD11b+ Siglec F+), and neutrophils (CD11b+ Ly-6G+) in BAL (top) and lung (bottom). e BAL levels of C–C chemokine CCL24 from WT and ADAMTS7−/− mice. Results show the mean ± S.E. and represent two or more independent experiments (n = 8–10 mice, unpaired t-test, *P < 0.01)
Fig. 2
Fig. 2
ADAMTS7−/− develops increased Th2 immune response to inhaled HDM. Frequency of CD4+IL13+and CD4+IL17+T-cells in a BAL and b lung; and c cytokine secretion by ex vivo cultures of DLn cells that had been re-stimulated with HDM (100 µg/ml). Results show the mean ± S.E. and represent two or more independent experiments (n = 8–10 mice, unpaired t-test, *P < 0.01). d Images show histopathological sections of HDM-challenged lung from WT or ADAMTS7−/− stained with H& E and PAS. Scale bars, 100 μm for × 100 and 50 μm for × 400 images. e Frequency of PAS+airways from HDM-challenged WT or ADAMTS7−/−mice. Results show the mean ± S.E. and represent two or more independent experiments (n = 6 mice, unpaired t-test, *P < 0.01)
Fig. 3
Fig. 3
Antigen uptake by DC and transport to the lung DLn is regulated by ADAMTS7. a Shown are the representative FACS dot plots of HDM-challenged WT and ADAMTS7−/− in the lung and DLn, and b the frequencies of OVA-AF647+CD11c+DCs (gated on SiglecF CD11c+ MHCIIhi population) from WT and ADAMTS7−/− mice 72 h after the allergen administration. Results represent the mean ± S.E, pooled from two independent experiments (n = 3–4 mice per group, *P < 0.05 unpaired t-test)
Fig. 4
Fig. 4
ADAMTS7 is a negative regulator of antigen priming and presentation function. a OVA-specific proliferation in OT-II cells are presented as a percentage divided. b Representative pseudocolor plots, c bar graphs of CD4+ GATA3+ OT-II cells, and Th2 cytokines d IL4 and e IL13 in BMDC-OTII coculture supernatant from WT and ADAMTS7−/− with and without OVA323-339 peptide. (n = 6 per group and represent one of the three repeats). Data represent the mean ± SE, *P < 0.01, unpaired t-test

References

    1. GBDCRD Collaborators Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. doi: 10.1016/S2213-2600(17)30293-X. - DOI - PMC - PubMed
    1. Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The Projected Economic and Health Burden of Uncontrolled Asthma in the United States. Am J Respir Crit Care Med. 2019;200:1102–1112. doi: 10.1164/rccm.201901-0016OC. - DOI - PMC - PubMed
    1. Moore WC, Hastie AT, Li XN, Li HS, Busse WW, Jarjour NN, Wenzel SE, Peters SP, Meyers DA, Bleecker ER, Severe NHLBI. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133:1557. doi: 10.1016/j.jaci.2013.10.011. - DOI - PMC - PubMed
    1. Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: moving toward precision medicine. J Allergy Clin Immunol. 2019;144:1–12. doi: 10.1016/j.jaci.2019.05.031. - DOI - PubMed
    1. Samitas K, Zervas E, Gaga M. T2-low asthma: current approach to diagnosis and therapy. Curr Opin Pulm Med. 2017;23:48–55. doi: 10.1097/Mcp.0000000000000342. - DOI - PubMed

Publication types